Rate of deaths by age/gender (per 100,000 population) for people killed in crashes involving a driver with BAC =>0.08%, 2012Source: Fatality Analysis Reporting System (FARS)Note: Blank cells indicate data are suppressed. Fatality rates based on fewer than 20 deaths are suppressed.
New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week.
Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders.
Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020.
In 2013 and subsequently, one question in the core of BRFSS asks about vision: Are you blind or do you have serious difficulty seeing, even when wearing glasses? From 2005-2011 the BRFSS employed a ten question vision module regarding vision impairment, access and utilization of eye care, and self-reported eye diseases. The Vision and Eye Health Surveillance System is intended to provide population estimates of vision loss function, eye diseases, health disparities, as well as barriers and facilitators to access to vision and eye care. This information can be used for designing, implementing, and evaluating vision and eye health prevention programs.
The 2011 BRFSS data reflects a change in weighting methodology (raking) and the addition of cell phone only respondents. Shifts in observed prevalence from 2010 to 2011 for BRFSS measures will likely reflect the new methods of measuring risk factors, rather than true trends in risk-factor prevalence. A break in trend lines after 2010 is used to reflect this change in methodolgy. Percentages are weighted to population characteristics. Data are not available if it did not meet BRFSS stability requirements.For more information on these requirements, as well as risk factors and calculated variables, see the Technical Documents and Survey Data for a specific year - http://www.cdc.gov/brfss/annual_data/annual_data.htm.Recommended citation: Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [appropriate year].
2015-2017. High School Dataset – Including Sexual Orientation. The Youth Risk Behavior Surveillance System (YRBSS) monitors six categories of priority health behaviors
among youth and young adults: 1) behaviors that contribute to unintentional injuries and violence; 2) tobacco use; 3) alcohol and
other drug use; 4) sexual behaviors related to unintended pregnancy and sexually transmitted infections (STIs), including human
immunodeficiency virus (HIV) infection; 5) unhealthy dietary behaviors; and 6) physical inactivity. In addition, YRBSS monitors
the prevalence of obesity and asthma and other priority health behaviors. This dataset contains national, state, and local data from 2015 that includes two aspects of sexual orientation – sexual identity and sex of sexual contacts. Additional information about the YRBSS can be found at www.cdc.gov/yrbss.
The provisional counts for coronavirus disease (COVID-19) deaths are based on a current flow of mortality data in the National Vital Statistics System. National provisional counts include deaths occurring within the 50 states and the District of Columbia as of the date specified that have been received and coded. It is important to note that it can take several weeks for death records to be submitted to National Center for Health Statistics (NCHS), processed, coded, and tabulated. Therefore, the data shown on this page may be incomplete, and will likely not include all deaths that occurred during a given time period especially for the more recent time periods. Death counts for earlier weeks are continually revised and may increase or decrease as new and updated death certificate data are received from the states by NCHS. COVID-19 death counts shown here may differ from other published sources, as data currently are lagged by an average of 1-2 weeks.
The provisional data presented on this page include the weekly provisional count of deaths in the United States due to COVID-19, deaths from all causes and percent of expected deaths (i.e., number of deaths received over number of deaths expected based on data from previous years), pneumonia deaths (excluding pneumonia deaths involving influenza), and pneumonia deaths involving COVID-19; (a) by week ending date, (b) by age at death, and (c) by specific jurisdictions. Future updates to this release may include additional detail such as demographic characteristics (e.g., sex), additional causes of death (e.g., acute respiratory distress syndrome or other comorbidities), or estimates based on models that account for reporting delays to generate more accurate predicted provisional counts.
Pneumonia deaths are included to provide context for understanding the completeness of COVID-19 mortality data and related trends. Deaths due to COVID-19 may be misclassified as pneumonia deaths in the absence of positive test results, and pneumonia may appear on death certificates as a comorbid condition. Thus, increases in pneumonia deaths may be an indicator of excess COVID-19-related mortality. Additionally, estimates of completeness for pneumonia deaths may provide context for understanding the lag in reporting for COVID-19 deaths, as it is anticipated that these causes would have similar delays in reporting, processing, and coding. However, it is possible that reporting of COVID-19 mortality may be slower or faster than for other causes of death, and that the delay may change over time. Analyses to better understand and quantify reporting delays for COVID-19 deaths and related causes are underway. The list of causes provided in these tables may expand in future releases as more data are received, and other potentially comorbid conditions are determined.
Comparing data in this report to other sources
Provisional death counts in this report will not match counts in other sources, such as media reports or numbers from county health departments. Death data, once received and processed by National Center for Health Statistics (NCHS), are tabulated by the state or jurisdiction in which the death occurred. Death counts are not tabulated by the decedent’s state of residence. COVID-19 deaths may also be classified or defined differently in various reporting and surveillance systems. Death counts in this report include laboratory confirmed COVID-19 deaths and clinically confirmed COVID-19 deaths. This includes deaths where COVID-19 is listed as a “presumed” or “probable” cause. Some local and state health departments only report laboratory-confirmed COVID deaths. This may partly account for differences between NCHS reported death counts and death counts reported in other sources. Provisional counts reported here track approximately 1–2 weeks behind other published data sources on the number of COVID-19 deaths in the U.S. (1,2,3).
Final counts of deaths by the week the deaths occurred, by state of occurrence, and by select causes of death for 2014-2019. Death counts in this dataset were derived from the National Vital Statistics System database that provides the most timely access to the data. Therefore, counts may differ slightly from final data due to differences in processing, recoding, and imputation.
2011-2018. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. BRFSS Survey Data. The BRFSS is a continuous, state-based surveillance system that collects information about modifiable risk factors for chronic diseases and other leading causes of death. The data for the STATE System were extracted from the annual BRFSS surveys from participating states. Tobacco topics included are cigarette and e-cigarette use prevalence by demographics, cigarette and e-cigarette use frequency, and quit attempts. NOTE: these data are not to be compared with BRFSS data collected 2010 and prior, as the methodologies were changed. Please refer to the FAQs / Methodology sections for more details.
This dataset includes data on adult's diet, physical activity, and weight status from Behavioral Risk Factor Surveillance System. This data is used for DNPAO's Data, Trends, and Maps database, which provides national and state specific data on obesity, nutrition, physical activity, and breastfeeding.
Source for 2012 national data: National Occupant Protection Use Survey (NOPUS), 2012. Source for 2014 national data: National Occupant Protection Use Survey (NOPUS), 2014. Source for 2012 state data: State Observational Survey of Seat Belt Use, 2012. Source for 2014 state data: Seat Belt Use in 2014- Use Rates in the States and Territories